Ramat Gan, Israel

Ran Shimon

This inventor holds 9 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Intel Corporation. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ran Shimon. Retrieved from https://idiyas.com/inventor/ran-shimon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8


Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Ramar Gan, IL (2017)
  • Ramat Gan, IL (2016 - 2022)
  • Giv'Atayim, IL (2021 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Ran Shimon: Pioneering Innovations in Ramat-Gan

Introduction: Ran Shimon is a visionary inventor based in Ramat-Gan, Israel, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ran Shimon holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Ran Shimon has worked with leading research institutions and tech companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Ran Shimon has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and excellence in all his projects.

Conclusion: Inventor Ran Shimon's relentless pursuit of innovation and his passion for creating solutions to complex challenges continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…